TyG-BMI and METS-IR best parameters for predicting hypertension risk in diabetics: Study
Germany: A recent study published in Diabetology & Metabolic Syndrome has shown triglyceride-glucose index with body mass index (TyG-BMI) and metabolic score for IR (METS-IR) to be independent risk factors for the prevalence of hypertension. Both the parameters (TyG-BMI and METS-IR) had good predictive value for the prevalence of hypertension, and TyG-BMI was superior to METS-IR.
Hypertension is one of the leading causes of disability-adjusted life years worldwide and is a critical public health challenge. Its prevalence is expected to increase globally, particularly in developing countries. The number of people affected by hypertension will likely increase to 1.56 billion by 2025. In this regard, it is essential to early identify specific populations at potential risk of hypertension development to lower mortality and disability associated with hypertension.
Various studies have examined the association between insulin resistance (IR) surrogates and hypertension risk. However, there is a lack of ambiguity on whether the differences exist between different IR surrogates and the risk of hypertension. Therefore, Siwei Chen, Department of Cardiovascular Medicine, The Third Hospital of Nanchang, Nanchang, Jiangxi, China, and colleagues aimed to investigate the association of four IR surrogates (TyG index, TyG-BMI, triglycerides/high-density lipoprotein cholesterol ratio (TG/HDL-c), and METS-IR)) with the prevalence of hypertension.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.